Editor's note: This is the fourth and final article in a series examining AI concentration risk in growth portfolios. The first, Your Diversified ETF Isn't as Diversified as You Think , examined how popular ETFs concentrate exposure to the AI capital spending cycle; the second, AI Is a Supply Chain Rather Than an Industry: Here's Why , mapped the supply chain layers behind that spending; the third, How to Manage the 4 Risks Hiding Inside Every AI-Heavy Portfolio , examined the risks facing the buildout itself.
A new frontier AI model now reaches the market every few weeks. No hospital system, manufacturer, bank or retailer refreshes its production technology stack on that schedule, and none ever will.
That mismatch is not a minor operational footnote. It is a structural risk sitting underneath the valuation of nearly every company in the AI supply chain, because those valuations assume enterprise revenue will arrive on the same clock as model releases.…